MYLAN 106 (ERYTHROMYCIN 250 MG)
Pill imprint MYLAN 106 has been identified as Erythromycin stearate 250 MG.
Erythromycin is used in the treatment of dental abscess; strep throat; chlamydia infection; skin infection; pneumonia (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 MG is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN 106 (ERYTHROMYCIN 250 MG)
- Imprint:
-
MYLAN 106
- Strength:
- 250 MG
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Macrolides
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
More resources
Erythromycin stearate is associated with the treatment of:
- Bacterial Endocarditis Prevention
- Bartonellosis
- Bowel Preparation
- Bronchitis
- Bullous Pemphigoid
- Campylobacter Gastroenteritis
- Chancroid
- Chlamydia Infection
- Dental Abscess
- Legionella Pneumonia
- Lyme Disease
- Lymphogranuloma Venereum
- Mycoplasma Pneumonia
- Nongonococcal Urethritis
- Ocular Rosacea
- Otitis Media
- Pemphigoid
- Pertussis
- Pharyngitis
- Pneumonia
- Rheumatic Fever Prophylaxis
- Skin Infection
- Strep Throat
- Syphilis, Early
- Upper Respiratory Tract Infection
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...


